Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 6 pp 4866—4878
MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer
Figure 2. ROC analysis demonstrating that serum miR-519d levels can distinguish NSCLC patients from healthy controls.